Fibroblasts as efficient antigen-presenting cells in lymphoid organs. 1995

T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
Institute of Experimental Immunology, University of Zürich, Switzerland.

Only so-called "professional" antigen-presenting cells (APCs) of hematopoietic origin are believed capable of inducing T lymphocyte responses. However, fibroblasts transfected with viral proteins directly induced antiviral cytotoxic T lymphocyte responses in vivo, without involvement of host APCs. Fibroblasts induced T cells only in the milieu of lymphoid organs. Thus, antigen localization affects self-nonself discrimination and cell-based vaccine strategies.

UI MeSH Term Description Entries
D007739 L Cells A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS. Earle's Strain L Cells,L Cell Line,L Cells (Cell Line),L-Cell Line,L-Cells,L-Cells, Cell Line,L929 Cell Line,L929 Cells,NCTC Clone 929 Cells,NCTC Clone 929 of Strain L Cells,Strain L Cells,Cell Line L-Cell,Cell Line L-Cells,Cell Line, L,Cell Line, L929,Cell Lines, L,Cell, L,Cell, L (Cell Line),Cell, L929,Cell, Strain L,Cells, L,Cells, L (Cell Line),Cells, L929,Cells, Strain L,L Cell,L Cell (Cell Line),L Cell Lines,L Cell, Strain,L Cells, Cell Line,L Cells, Strain,L-Cell,L-Cell Lines,L-Cell, Cell Line,L929 Cell,Strain L Cell
D008216 Lymphocytic Choriomeningitis A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Armstrong Syndrome,Armstrong's Syndrome,Encephalomyelitis, Lymphocytic Choriomeningitis Virus,Lymphocytic Choriomeningitis Virus Encephalomyelitis,Choriomeningitis, Lymphocytic,Syndrome, Armstrong,Syndrome, Armstrong's
D008217 Lymphocytic choriomeningitis virus The type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host. LCM Viruses,LCMV,LCM Virus,Lymphocytic choriomeningitis viruses
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
January 2016, Frontiers in immunology,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
January 2017, Theranostics,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
December 2010, Nature reviews. Immunology,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
June 2018, Immunity, inflammation and disease,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
December 2013, Investigacion clinica,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
December 2021, Nature,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
March 2001, The Journal of clinical investigation,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
May 2016, Immunological reviews,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
July 1980, The Journal of investigative dermatology,
T M Kündig, and M F Bachmann, and C DiPaolo, and J J Simard, and M Battegay, and H Lother, and A Gessner, and K Kühlcke, and P S Ohashi, and H Hengartner
July 1994, Immunology today,
Copied contents to your clipboard!